X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (354) 354
Publication (35) 35
Book Chapter (3) 3
Book Review (2) 2
Magazine Article (2) 2
Patent (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (195) 195
male (133) 133
female (110) 110
cardiac & cardiovascular systems (101) 101
middle aged (101) 101
adult (85) 85
index medicus (66) 66
aged (62) 62
chagas cardiomyopathy - physiopathology (32) 32
cardiomyopathy (31) 31
echocardiography (28) 28
medicine, general & internal (28) 28
chronic disease (27) 27
heart diseases (27) 27
medicine, research & experimental (27) 27
myocardial infarction (27) 27
risk factors (27) 27
abridged index medicus (26) 26
heart-disease (25) 25
treatment outcome (25) 25
biology (23) 23
chagas' disease (23) 23
mortality (23) 23
medicine (22) 22
cardiology (21) 21
chagas disease (21) 21
disease (21) 21
animals (19) 19
cardiovascular disease (18) 18
prospective studies (18) 18
cardiovascular (17) 17
care and treatment (17) 17
electrocardiography (17) 17
heart failure (17) 17
heart rate (17) 17
time factors (17) 17
double-blind method (16) 16
drug therapy (16) 16
follow-up studies (16) 16
adolescent (15) 15
cardiovascular diseases (15) 15
chagas cardiomyopathy - diagnostic imaging (15) 15
clinical trials (15) 15
analysis (14) 14
cardiovascular diseases - prevention & control (14) 14
heart attacks (14) 14
parasitology (14) 14
stroke (14) 14
chagas cardiomyopathy - complications (13) 13
drug therapy, combination (13) 13
exercise test (13) 13
heart rate - drug effects (13) 13
stroke volume (13) 13
tropical medicine (13) 13
ventricular dysfunction, left - diagnostic imaging (13) 13
diseases of the circulatory system (12) 12
myocardial-infarction (12) 12
parasitic diseases (12) 12
patients (12) 12
prevention (12) 12
prognosis (12) 12
risk (12) 12
trypanocidal agents - therapeutic use (12) 12
blood pressure (11) 11
chagas cardiomyopathy - diagnosis (11) 11
chagas cardiomyopathy - drug therapy (11) 11
heart (11) 11
hemodynamics (11) 11
medicine & public health (11) 11
pathogenesis (11) 11
percutaneous coronary intervention (11) 11
radiology, nuclear medicine & medical imaging (11) 11
atropine - pharmacology (10) 10
cardiovascular diseases - mortality (10) 10
dysfunction (10) 10
exercise (10) 10
imaging / radiology (10) 10
life sciences (10) 10
nuclear medicine (10) 10
parasympathetic nervous system - physiopathology (10) 10
predictive value of tests (10) 10
risk assessment (10) 10
severity of illness index (10) 10
trypanosoma-cruzi infection (10) 10
ventricular dysfunction, left - physiopathology (10) 10
autonomic nervous system - physiopathology (9) 9
benznidazole (9) 9
brazil (9) 9
chagas disease - physiopathology (9) 9
coronary angiography (9) 9
diagnosis (9) 9
infections (9) 9
magnetic resonance imaging (9) 9
myocardial contraction (9) 9
myocardial infarction - drug therapy (9) 9
nitroimidazoles - therapeutic use (9) 9
research (9) 9
research article (9) 9
thallium radioisotopes (9) 9
aged, 80 and over (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 12/2013, Volume 310, Issue 23, pp. 2510 - 2522
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article